Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Feb 2026
Amy Bachrodt SVP, Finance
Sold on a plan 3×
$230.22K 5,000 at 46.04
27.8%
Planned (10b5-1)
2 Feb 2026
Raymond Woo Chief Technology Officer
Sold on a plan 3×
$228.38K 11,112 at 20.55
6.2%
Planned (10b5-1)
2 Feb 2026
Todd Krasnow Director · indirect
Sold on a plan 4×
$214.93K 4,000 at 53.73
100%
Sold half or more
2 Feb 2026
Robert J Mylod Jr Director · indirect
Sold on a plan 15×
$204.21K 40 at 5,105.36
4.5%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$202.48K 1,100 at 184.07
1.4%
Planned (10b5-1)
2 Feb 2026
Neil D Hunt Director
Sold on a plan 4×
$192.96K 2,000 at 96.48
20.4%
Planned (10b5-1)
2 Feb 2026
Artur Bergman Chief Technology Officer
Sold on a plan
$187.20K 20,000 at 9.36
0.8%
Planned (10b5-1)
2 Feb 2026
Gabriel Brooks Chief Medical Officer
Sold on a plan
$182.39K 28,335 at 6.44
22.7%
Planned (10b5-1)
2 Feb 2026
Chad Roberts EVP, Production Solutions
Sold on a plan
$178.04K 8,300 at 21.45
6.4%
Planned (10b5-1)
2 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 2×
$173.44K 857 at 202.38
0.0%
Planned (10b5-1)
2 Feb 2026
Kevin Tan CFO & Treasurer
Sold on a plan
$172.75K 26,837 at 6.44
19.8%
Planned (10b5-1)
2 Feb 2026
Jessie Hanrahan Chief Regulatory Officer
Sold on a plan
$170.80K 26,535 at 6.44
24.3%
Planned (10b5-1)
2 Feb 2026
Vicki L Sato Director
Sold on a plan
$169.67K 22,000 at 7.71
1.9%
Planned (10b5-1)
2 Feb 2026
Paul Herzich Chief Technology Officer
Sold on a plan
$168.97K 26,250 at 6.44
24.7%
Planned (10b5-1)
2 Feb 2026
Michael George Rosenbaum Chief Executive Officer
Sold on a plan
$168.01K 1,200 at 140.01
0.5%
Planned (10b5-1)
2 Feb 2026
Surya Gummadi President - Americas
Sold on a plan
$143.52K 1,728 at 83.06
6.3%
Planned (10b5-1)
2 Feb 2026
Paul D Rubin Chief Medical Officer
Sold on a plan
$139.37K 7,433 at 18.75
100%
Sold half or more
2 Feb 2026
John Wendell Thompson Director · indirect
Sold on a plan 3×
$138.26K 2,500 at 55.30
8.8%
Planned (10b5-1)
2 Feb 2026
Priya Singhal Head of Development
Sold on a plan
$134.12K 748 at 179.30
10.7%
Planned (10b5-1)
2 Feb 2026
Jane Henderson Chief Financial Officer
Sold on a plan 3×
$131.63K 2,000 at 65.81
1.1%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$126.79K 1,125 at 112.70
1.0%
Planned (10b5-1)
2 Feb 2026
Jennifer Vecchio Group President and CMO
Sold on a plan 5×
$124.69K 419 at 297.60
0.7%
Planned (10b5-1)
2 Feb 2026
Shane Kapral Deputy Chief Financial Officer
Sold on a plan
$124.46K 616 at 202.04
17.9%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$120.59K 10,000 at 12.06
0.5%
Planned (10b5-1)
2 Feb 2026
Barry M Smith Director
Sold on a plan
$120.08K 700 at 171.54
2.9%
Planned (10b5-1)
2 Feb 2026
Nicholas Grund Chief Commercial Officer
Sold on a plan 2×
$117.91K 84,829 at 1.39
13.1%
Planned (10b5-1)
2 Feb 2026
Rebecca L Charlton SVP, Controller & CAO
Sold on a plan
$110.70K 1,985 at 55.77
14.1%
Planned (10b5-1)
2 Feb 2026
Gary K. Schick SVP, CHRO
Sold on a plan 7×
$102.87K 422 at 243.77
1.0%
Planned (10b5-1)
2 Feb 2026
Carolyn M. Rucci SVP, Chief Legal Officer
Sold on a plan 3×
$96.98K 69,772 at 1.39
10.6%
Planned (10b5-1)
2 Feb 2026
Steven Keith Burke SVP, Chief Medical Officer
Sold on a plan 3×
$94.04K 67,658 at 1.39
6.7%
Planned (10b5-1)
2 Feb 2026
Patrick Burnett See Remarks
Sold on a plan
$93.71K 3,675 at 25.50
3.9%
Planned (10b5-1)
2 Feb 2026
John W Kozarich Director
Sold on a plan 5×
$91.49K 467 at 195.91
1.1%
Planned (10b5-1)
2 Feb 2026
Michael W Pope Director
Sold on a plan
$88.13K 544 at 162.00
8.5%
Planned (10b5-1)
2 Feb 2026
John McCartney Director
Sold on a plan
$84.39K 500 at 168.77
1.2%
Planned (10b5-1)
2 Feb 2026
Orbimed Advisors LLC Director · indirect also filed by Peter A. Thompson
Sold on a plan
$84.24K 1,890 at 44.57
0.1%
Planned (10b5-1)
2 Feb 2026
Lauren Riker Senior Vice President, Finance
Sold on a plan
$83.24K 4,000 at 20.81
7.1%
Planned (10b5-1)
2 Feb 2026
Steven Yi See Remarks
Sold on a plan
$82.55K 8,000 at 10.32
0.3%
Planned (10b5-1)
2 Feb 2026
Rosty Raykov Director
Sold on a plan
$80.31K 10,349 at 7.76
9.5%
Planned (10b5-1)
2 Feb 2026
Paul L Alpern VP and General Counsel
Sold on a plan
$77.38K 5,000 at 15.48
8.0%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$74.66K 2,000 at 37.33
9.2%
Planned (10b5-1)
2 Feb 2026
Howard Horn Chief Financial Officer
Sold on a plan
$72.12K 3,061 at 23.56
3.3%
Planned (10b5-1)
2 Feb 2026
Eric Meurice Director
Sold on a plan
$71.25K 750 at 95.00
3.2%
Planned (10b5-1)
2 Feb 2026
Alec Amar President
Sold on a plan
$69.58K 27,500 at 2.53
2.1%
Planned (10b5-1)
2 Feb 2026
Eugene Nonko Director · indirect
Sold on a plan
$69.38K 6,700 at 10.36
0.5%
Planned (10b5-1)
2 Feb 2026
Richard C Malabre SVP, Chief Accounting Officer
Sold on a plan 2×
$68.84K 49,524 at 1.39
14.2%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$67.51K 400 at 168.77
1.9%
Planned (10b5-1)
2 Feb 2026
Mark A Welsh III Director
Sold on a plan 12×
$65.03K 95 at 684.52
2.2%
Planned (10b5-1)
2 Feb 2026
Pramod Badjate President & GM, NFB
Sold on a plan
$62.91K 3,000 at 20.97
2.0%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$60.46K 400 at 151.14
0.7%
Planned (10b5-1)
Showing 17,801–17,850 of 23,258. ← Newer Page 357 of 466 Older →